Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ohio State University | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
This open label, between-subject, randomized multi-center pilot study will assess the feasibility of conducting a study remotely with telehealth visits to assess the effect of cigarettes with minimal filter ventilation vs. moderate filter ventilation on smoking behavior and biomarkers of tobacco toxicant exposure. Subjective measures, alveolar carbon monoxide, blood pressure and cigarettes per a day will be collected remotely. Biological samples will be collected at home and mailed to the study clinic.
Smokers of cigarettes with about 16-30% ventilation in their conventional cigarettes who meet eligibility criteria will enter 3 weeks of monitoring of usual brand smoking. Subjects will then be randomly assigned for a period of 6 weeks to one of two conditions: 1) ventilated cigarettes; or 2) unventilated cigarettes. Subjects in each condition will be unblinded to simulate real world conditions. Subjects are provided with a debit card (ClinCard) that has been loaded with the appropriate amount of money to cover self-purchased usual brand cigarette in baseline and the assigned study cigarettes during intervention. Weekly telehealth visits will be conducted during baseline and the 6 weeks on study cigarettes to collect study measures, followed by a one month follow-up.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Unventilated Filter Cigarette | Experimental | Conventional cigarette with approximately 6-7% (non-menthol) and 5-6% filter ventilation (menthol). |
|
| Ventilated Filter Cigarette | Active Comparator | Conventional cigarette with approximately 22-26% (non-menthol) and 35-38% filter ventilation (menthol). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Unventilated filter cigarettes | Other | Currently marketed unventilated cigarettes |
|
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of approach - Drop outs | Percent of drop-outs in baseline and post-randomization. | Baseline through Week 6 |
| Feasibility of approach - Missing Data | Extent (percent) of missing data | Baseline through Week 6 |
| Feasibility of approach - Participant Satisfaction | Degree of difficulty collecting data through telehealth visits, mailing in biosamples and self-purchase of cigarettes (descriptive statistics (e.g., percent or mean responses) | Baseline through Week 6 |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Total Nicotine Equivalents (TNE) | The sum of nicotine and its metabolite concentrations used for evaluating nicotine exposure. | effect size for each arm calculated as the baseline minus the 6 week value divided by the SD of this difference |
| Change in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dorothy Hatsukami, PH.D | Masonic Cancer Center, University of Minnesota | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Minnesota | Minneapolis | Minnesota | 55405 | United States | ||
| The Ohio State University Comprehensive Cancer Center |
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | May 14, 2026 | |
| Reset | Jun 9, 2026 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| May 14, 2026 | Jun 9, 2026 | |||
| Jul 7, 2026 |
| ID | Term |
|---|---|
| D064424 | Tobacco Use |
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided
Open label, between-subject, randomized multi-center pilot study
Not provided
Not provided
Not provided
Not provided
| Ventilated filter cigarettes | Other | Currently marketed ventilated cigarettes |
|
One of the tobacco specific nitrosamines, one of the most important groups of carcinogens in tobacco products, which are formed from nicotine during the curing and processing of tobacco. |
| effect size for each arm calculated as the baseline minus the 6 week value divided by the SD of this difference |
| Change in mean cigarettes per day (CPD) | The change in mean cigarettes per day (CPD) based on 7 day ITR data before visit 00 and week 6 visit. | effect size for each arm calculated as the baseline minus the 6 week value divided by the SD of this difference |
| Columbus |
| Ohio |
| 43210 |
| United States |